Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00762931 · ClinicalTrials.gov registry record · NA
Neurostimulation for the Relief of Acute Bronchoconstriction
A NA study of Asthma, sponsored by ElectroCore.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 6
- Study locations
NCT00762931: Completed NA study of Asthma, sponsored by ElectroCore.
NCT00762931 is a NA study of Asthma that has completed, run by ElectroCore. The registered enrollment target is 25 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (98% lower). The trial reports 6 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00762931, a NA study of Asthma, has completed, sponsored by ElectroCore.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 6
- Study locations
Study Summary
The goal of this study is to validate design for the Resolve™ Stimulator and Proximity Electrode and the associated procedure to quickly and safely place an electrode into the neck, in the vicinity of the vagus nerve by a physician in either the Emergency Department or other appropriate hospital inpatient setting (e.g., ICU). The secondary goal is to confirm that the electrical signal being delivered via this electrode rapidly counters bronchoconstriction and improves airway flow.
Primary Outcome
Safety- Number of participants that reported Adverse Events
Conditions Studied
Interventions
- DEVICE Resolve Stimulator and Proximity Lead
Study Locations (6)
Michigan
- Henry Ford Health System - Detroit
- William Beaumont Hospital - Royal Oak
Illinois
- Rush University Medical Center - Chicago
Minnesota
- Hennepin County Medical Center - Minneapolis
Missouri
- Washington University School of Medicine, Barnes-Jewish Hospital, - St Louis
Texas
- Dorrington Medical Associates - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2008-09 |
| Est. Completion | 2010-10 |
| Phase | NA |
What the finished NCT00762931 record still lists
NCT00762931 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which Resolve Stimulator and Proximity Lead is the first listed.
NCT00762931 lists 6 locations in 5 states (Michigan, Illinois, Minnesota).
Frequently Asked Questions
What is clinical trial NCT00762931 about?
NCT00762931 is a clinical study titled "Neurostimulation for the Relief of Acute Bronchoconstriction". The goal of this study is to validate design for the Resolve™ Stimulator and Proximity Electrode and the associated procedure to quickly and safely place an electrode into the neck, in the vicinity of the vagus nerve by a physician in either the Emergency Department or other appropriate hospital inp...
What is the current status of trial NCT00762931?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2008-09. Estimated completion is 2010-10.
What conditions does trial NCT00762931 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT00762931?
The interventions under investigation include: Resolve Stimulator and Proximity Lead (DEVICE).
Who is sponsoring clinical trial NCT00762931?
This trial is sponsored by ElectroCore, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00762931 being conducted?
This trial has 6 study locations across Illinois, Michigan, Minnesota, Missouri, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00762931's enrollment target sits among peer trials
25 318th of 374 higher than 50 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Reducing Overuse of Antibiotics With Decision Support
RECRUITING · NA
-
ASTHMAXcel Voice Study
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Asthma and Technology in Emerging African American Adults
RECRUITING · NA
-
BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia